bioAffinity Technologies (BIAF) Gross Margin: 2022-2025
Historic Gross Margin for bioAffinity Technologies (BIAF) over the last 4 years, with Sep 2025 value amounting to 34.84%.
- bioAffinity Technologies' Gross Margin fell 388.00% to 34.84% in Q3 2025 from the same period last year, while for Sep 2025 it was 27.86%, marking a year-over-year decrease of 717.00%. This contributed to the annual value of 36.09% for FY2024, which is 483.00% up from last year.
- According to the latest figures from Q3 2025, bioAffinity Technologies' Gross Margin is 34.84%, which was up 74.92% from 19.92% recorded in Q2 2025.
- Over the past 5 years, bioAffinity Technologies' Gross Margin peaked at 100.00% during Q2 2022, and registered a low of 19.92% during Q2 2025.
- Moreover, its 3-year median value for Gross Margin was 34.84% (2025), whereas its average is 46.26%.
- As far as peak fluctuations go, bioAffinity Technologies' Gross Margin tumbled by 6,776bps in 2023, and later surged by 446bps in 2024.
- bioAffinity Technologies' Gross Margin (Quarterly) stood at 92.54% in 2022, then slumped by 6,776bps to 24.78% in 2023, then spiked by 446bps to 29.24% in 2024, then tumbled by 388bps to 34.84% in 2025.
- Its last three reported values are 34.84% in Q3 2025, 19.92% for Q2 2025, and 26.21% during Q1 2025.